CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 119 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q3 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,976,488 | -31.3% | 90,540 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $2,878,267 | +75.6% | 90,540 | +34.7% | 0.00% | 0.0% |
| Q1 2023 | $1,639,008 | -22.7% | 67,200 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $2,119,488 | +11.6% | 67,200 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $1,899,000 | +14.4% | 67,200 | +7.0% | 0.00% | 0.0% |
| Q2 2022 | $1,660,000 | -4.0% | 62,800 | +27.1% | 0.00% | 0.0% |
| Q1 2022 | $1,729,000 | -28.4% | 49,400 | -33.7% | 0.00% | 0.0% |
| Q4 2021 | $2,414,000 | +40.8% | 74,454 | +28.1% | 0.00% | 0.0% |
| Q3 2021 | $1,715,000 | +108.9% | 58,130 | +81.5% | 0.00% | – |
| Q2 2021 | $821,000 | – | 32,030 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BAIN CAPITAL INVESTORS LLC | 60,632,356 | $1,713,470,000 | 41.39% |
| Perceptive Advisors | 6,511,727 | $184,021,000 | 5.34% |
| Finepoint Capital LP | 536,901 | $15,173,000 | 4.99% |
| Artal Group S.A. | 2,000,000 | $56,520,000 | 2.41% |
| Rock Springs Capital Management LP | 2,499,148 | $70,626,000 | 1.82% |
| Ikarian Capital, LLC | 178,100 | $5,033,000 | 1.00% |
| Hood River Capital Management LLC | 896,572 | $25,337,000 | 0.97% |
| Frazier Life Sciences Management, L.P. | 393,000 | $11,106,000 | 0.86% |
| HighVista Strategies LLC | 23,611 | $667,000 | 0.38% |
| FEDERATED HERMES, INC. | 3,313,333 | $93,635,000 | 0.27% |